{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:10:35Z","timestamp":1760177435072,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ecl.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T12:11:08Z","timestamp":1415275868000},"page":"127-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hypopituitarism"],"prefix":"10.1016","volume":"44","author":[{"given":"Cristina","family":"Capatina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.H.","family":"Wass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"issue":"9372","key":"10.1016\/j.ecl.2014.11.002_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-10-0914","article-title":"Dutch National Registry of GH Treatment in Adults: patient characteristics and diagnostic test procedures","volume":"164","author":"van Nieuwpoort","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/jc.2008-0713","article-title":"Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database","volume":"94","author":"Webb","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.02191","article-title":"Incidence of GH deficiency\u2014a nationwide study","volume":"155","author":"Stochholm","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib7","first-page":"833","article-title":"Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis","volume":"75","author":"de","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2014.11.002_bib8","first-page":"2877","article-title":"Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1530\/EJE-09-0266","article-title":"Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations","volume":"161","author":"Koltowska-Haggstrom","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/ENDO:12:2:153","article-title":"Cardiovascular effects of growth hormone","volume":"12","author":"Brickman","year":"2000","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib11","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9254","key":"10.1016\/j.ecl.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2006-1487","article-title":"A\u00a010-year, prospective study of the metabolic effects of growth hormone replacement in adults","volume":"92","author":"Gotherstrom","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.ecl.2014.11.002_bib14","first-page":"131","article-title":"Fracture rates in patients with growth hormone deficiency","volume":"54","author":"Wuster","year":"2000","journal-title":"Horm Res"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib15","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-12-1088","article-title":"Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review","volume":"169","author":"Appelman-Dijkstra","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1530\/eje.0.148s009","article-title":"Long-term experience with GH replacement therapy: efficacy and safety","volume":"148","author":"Monson","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2014.11.002_bib19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ecl.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2012-2940","article-title":"Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy","volume":"98","author":"Claessen","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2014.11.002_bib23","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","article-title":"Inflammatory cardiovascular risk markers in women with hypopituitarism","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","article-title":"Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults","volume":"136","author":"Markussis","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib26","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2265.2003.01794.x","article-title":"Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency","volume":"59","author":"Aimaretti","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8905","key":"10.1016\/j.ecl.2014.11.002_bib29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth-hormone deficiency in adults","volume":"343","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.ecl.2014.11.002_bib30","first-page":"21","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.ecl.2014.11.002_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.ijo.0800356","article-title":"Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency","volume":"21","author":"Maccario","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2002.01472.x","article-title":"Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults","volume":"56","author":"Gomez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-07-0066","article-title":"A\u00a0simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency","volume":"157","author":"Chihara","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"9236","key":"10.1016\/j.ecl.2014.11.002_bib36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(00)02755-0","article-title":"GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults","volume":"356","author":"Popovic","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ecl.2014.11.002_bib37","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults","volume":"83","author":"Drake","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2265.2009.03612.x","article-title":"Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects","volume":"72","author":"Woodmansee","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.ecl.2014.11.002_bib39","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","article-title":"Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis","volume":"96","author":"Attanasio","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/dc11-0449","article-title":"Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study","volume":"35","author":"Luger","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-14-0069","article-title":"Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults","volume":"171","author":"van Bunderen","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib42","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.2008.03391.x","article-title":"GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence","volume":"70","author":"Arnold","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","article-title":"Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement","volume":"63","author":"Chung","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2014.11.002_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9935","key":"10.1016\/j.ecl.2014.11.002_bib46","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1987.tb00780.x","article-title":"Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency","volume":"26","author":"Hagg","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 7","key":"10.1016\/j.ecl.2014.11.002_bib48","first-page":"74","article-title":"Dynamic evaluation of adrenal hypofunction","volume":"26","author":"Nieman","year":"2003","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.ecl.2014.11.002_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11154-005-5224-0","article-title":"Diagnosis and treatment of ACTH deficiency","volume":"6","author":"Cooper","year":"2005","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"10.1016\/j.ecl.2014.11.002_bib50","first-page":"2350","article-title":"Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test","volume":"83","author":"Erturk","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2014.11.002_bib51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.1994.tb03011.x","article-title":"The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis","volume":"40","author":"Fiad","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00009","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.ecl.2014.11.002_bib53","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM198206173062405","article-title":"Discordant cortisol response to exogenous ACTH and insulin-induced hypoglycemia in patients with pituitary disease","volume":"306","author":"Borst","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"8596","key":"10.1016\/j.ecl.2014.11.002_bib54","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(88)92020-X","article-title":"A\u00a0rational approach for assessing the hypothalamo-pituitary-adrenal axis","volume":"1","author":"Stewart","year":"1988","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ecl.2014.11.002_bib55","first-page":"2726","article-title":"The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency","volume":"83","author":"Thaler","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7861\/clinmedicine.8-2-211","article-title":"Adrenal insufficiency","volume":"8","author":"Arlt","year":"2008","journal-title":"Clin Med"},{"issue":"3","key":"10.1016\/j.ecl.2014.11.002_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","article-title":"An assessment of optimal hydrocortisone replacement therapy","volume":"46","author":"Howlett","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2014.11.002_bib58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-12-0351","article-title":"Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency","volume":"167","author":"Benson","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"14","key":"10.1016\/j.ecl.2014.11.002_bib59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2014.11.002_bib60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ando.2007.06.018","article-title":"DHEA: why, when, and how much\u2014DHEA replacement in adrenal insufficiency","volume":"68","author":"Allolio","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"10.1016\/j.ecl.2014.11.002_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852914001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852914001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:05Z","timestamp":1760175545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852914001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0889852914001121"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2014.11.002","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypopituitarism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}